Latest return on equity
Candel Therapeutics Return on equity
Direct answer
Candel Therapeutics's return on equity is -81.84%.
The verified market snapshot reports -81.84%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 12, 2026.
Get free Candel Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -81.84%
Explore related company data
View Candel Therapeutics's market capitalizationView Candel Therapeutics's price-to-book ratioView Candel Therapeutics's 52-week price rangeView Candel Therapeutics's profit marginView Candel Therapeutics's debt-to-equity ratioView all Candel Therapeutics key metricsReturn to Candel Therapeutics profile